GMP PHARMA CONGRESS, MARCH 20th, 2024
As a part of the GMP Pharma Congress, you can look forward to an exciting presentation by our Senior GMP Project Manager Dr Carsten Börger in collaboration with Frank Hesseler from Schlafender Hase. The topic of the presentation is the ,,Development and validation of a cloud-based system for automated text verification''. Information and registration form can be found here. >>>
CHAMPALIMAUD FOUNDATION: ATMP WORKSHOPS, APRIL 24th-26th, 2024
Visit the Champalimaud TIL workshop (Tumor Infiltrating Lymphocytes) for the treatment of patients with solid cancers and the APV Summer School for producing ATMPs, either separately or in combination. >>>
APV SEMINAR, MAY 14th-15th, 2024
The seminar will cover biopharma stability and cold stability for biologics/therapeutic proteins, with topics such as mechanisms of freezing, control of freezing & thawing, modelling, equipment, stabilisation by excipients, R&D strategies and alternative methods.
Further information and the registration form can be found here. >>>
CULT.TAINER WEB SESSION, JANUARY 30th, 2024
In this webinar, we will introduce the cult.tainer® concept, a turnkey production solution for GMP-compliant iATMPs. For further details and the registration formular, click here. >>>
VIRTUAL LECTURES GMP-BASICS I-III, NOVEMBER 3 & 4 & 24, 2023
The lecture by Dr. Hans-Georg Eckert, Managing Director and Senior Consultant of Valicare GmbH, will take place as part of the Master's Course MSc Bioanalytical Chemistry and Pharmaceutical Analysis at Fresenius University in Idstein. The three virtual training modules will be offered free of charge via Zoom. For further details and the access link, please click here. >>>
ISPE-ATMP SEMINAR, NOVEMBER 20 & 21, 2023
An ISPE DACH ATMP seminar focusing on aseptic processing technologies in the pharmaceutical industry. The event will include a tour of the Robert Bosch Hospital. More details about the event can be found on the linked website. >>>
7TH CELL THERAPY SYMPOSIUM, NOVEMBER 3 & 4, 2023
We are excited to be part of this year's 6th Cell Therapy Symposium at Heidelberg University Hospital. This symposium serves as a platform for the latest advancements in cell therapy.
Welcome to Valicare!
GMP for manufacturers in pharma, biotech, medical devices & ATMPs.
We have been offering a broad spectrum of classical and special GMP services for over 20 years now. Our GMP experts will advise and support you.Learn more
ATMP news from around the world
Our international press review contains a selection of news and recent articles on advanced therapy medicinal products (ATMPs), chimeric antigen receptor T-cell therapy (CAR), tumor infiltrating lymphocytes (TILs) and bioengineered tissue products (TEPs).
Reducing Turnaround Time of Axi-Cel CAR T-Cells17.02.2024 | CGTLive
Chris McDonald, senior vice president and global head of technical operations, Kite Pharma, discussed axi-cel's FDA approved manufacturing ...
Equal Censoring But Still Informative: When The Reasons For Censoring Differ Between Treatment Arms.17.02.2024 | European Journal Of Cancer
Excess toxicity or patient disappointment may lead to unequal informative censoring ...
FDA OKs Lifileucel Treatment for Advanced Melanoma16.02.2024 | Targeted Oncology
The FDA has approved lifileucel, a tumor infiltrating lymphocyte therapy, for the treatment of advanced melanoma.
Previously ignored DNA sequence16.02.2024 | Innovations Report
Professor Tomohisa Toda, Erlangen (left), and Professor Rusty Gage, La Jolla (right) © Salk Institute … plays ...
Capitalizing on the Boom in Biotherapies16.02.2024 | News-Research
The production of biopharmaceuticals often requires modifying the genetic heritage of cells and cultivating them ...
Protons are the new first responders16.02.2024 | Science.org
Stimulator of interferon genes (STING), upon sensing danger signals, acts as a channel and induces the leakage of protons from Golgi bodies ...
Stem cells in disguise16.02.2024 | Science.org
The discovery that our immune system not only provides constant surveillance against the development of neoplastic disorders but may also ...
What’s Trending: Parenteral Drug Development & Manufacturing15.02.2024 | DCAT Value Chain Insights
What is Trending: Parenteral Drug Manufacturing To gain a perspective on the key trends in parenteral drug development and manufacturing, ...
FDA's CBER Issues Final Guidance For CAR T Cell Products15.02.2024 | BioProcess Online
By Annie Lamontagne and Wendy Liang, Dark Horse Consulting Group The FDA issued the final guidance document, Considerations for the ...
New Mechanism Reveals How Tumors Evade Immune Detection15.02.2024 | Labroots
Scientists have dedicated their lives to finding a cure for cancer. America became a science hub for cancer research, particularly after ...
Addressing The GMP Skills Shortage With Virtual Reality14.02.2024 | BioProcess Online
By Tyler Menichiello , contributing editor copyright FourPlus Immersive Ltd Last March, the Alliance For Regenerative Medicine released a ...
How to navigate complexities of micro moulding for medical devices14.02.2024 | Medical Buyer
Micro moulding is a specialised form of injection moulding that produces extremely small, high-precision parts, often with intricate ...
Mit 3D-Druck zu künstlichem Knorpel14.02.2024 | medizin & technik
Tissue Engineering Mit 3D-Druck zu künstlichem Knorpel ...
FDA Updates for the Week of Feb. 5, 2024: Review Dates and Advisory Committee Meetings Scheduled10.02.2024 | Managed Healthcare Executive
The FDA has set PDUFA dates for several products: Arexvy to prevent RSV in 50 to the 59 population, for acoramidis in heart failure ...
EMA Accepts Three Organizations into ATMP Pilot Program09.02.2024 | Pharmaceutical Technology
The three non-commercial developers of ATMPs will benefit from enhanced support from the agency.